Literature DB >> 10146900

Cost effectiveness of hepatitis B immunisation strategies.

A L Hillman, I Blasco, B S Bloom, J S Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 10146900     DOI： 10.2165/00019053-199405020-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

1.  Benefit-cost analysis of hepatitis B vaccine programs for occupationally exposed workers.

Authors:  J A Mauskopf; C J Bradley; M T French
Journal:  J Occup Med       Date:  1991-06

2.  Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.

Authors:  K J Lo; S D Lee; Y T Tsai; T C Wu; C Y Chan; G H Chen; C L Yeh
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

3.  Development of recommendations for control of hepatitis B virus infections: the role of cost analysis.

Authors:  H S Margolis; G C Schatz; M A Kane
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

4.  Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.

Authors:  M Krahn; A S Detsky
Journal:  Med Decis Making       Date:  1993 Jan-Mar       Impact factor: 2.583

5.  The counseling practices of internists.

Authors:  C E Lewis; C Clancy; B Leake; J S Schwartz
Journal:  Ann Intern Med       Date:  1991-01-01       Impact factor: 25.391

6.  Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

Authors:  A G Mulley; M D Silverstein; J L Dienstag
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

7.  Accuracy of immunization histories provided by adults accompanying preschool children to a pediatric emergency department.

Authors:  K P Goldstein; F J Kviz; R S Daum
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

8.  A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.

Authors:  B S Bloom; A L Hillman; A M Fendrick; J S Schwartz
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

9.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

Authors:  R B Wainwright; B J McMahon; L R Bulkow; D B Hall; M A Fitzgerald; A P Harpster; S C Hadler; A P Lanier; W L Heyward
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

10.  Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.

Authors:  S C Hadler; D P Francis; J E Maynard; S E Thompson; F N Judson; D F Echenberg; D G Ostrow; P M O'Malley; K A Penley; N L Altman
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.